Clinical study of the anesthetic efficacy of 2% lidocaine gel versus tetracaine/oxybuprocaine anesthetic eye drops in patients operated on for glaucoma and undergoing needing techniques in outpatient surgery
EU CTIS ID: 2023-505802-40-02
What this study is testing
To compare the anaesthetic efficacy of 2% lidocaine gel with 0.1% hydrochloride tetracaine eye drops / 0.4% oxybuprocaine hydrochloride in the in-office needling procedure in glaucoma surgery patients. To determine the mean procedure time in both anaesthetic treatment arms.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients operated on glaucoma surgery with filter blister who require the needling procedure
- Patients over 18 years of age, who have understood and signed the informed consent.
You likely can't join if
- Pregnant or lactating patients.
- Patients with cognitive impairment who do not understand the visual analogue scale.
- Hearing loss that prevents the patient from collaborating
- Anxiety disorder that prevents patient's collaboration during the procedure
- Allergy to topical anesthetics
- Patients who require needling in the operating room
The study team makes the final eligibility decision.
Where it's taking place
- Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from EU CTIS. The study team decides eligibility, and your own doctor gives medical advice.